MOAEY yields 647.25% · PFE yields 6.13%● Live data
📍 MOAEY pulled ahead of the other in Year 1
Combined, MOAEY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MOAEY + PFE for your $10,000?
Mongolia Energy Corporation Limited, an investment holding company, engages in the coal mining, exploration, processing, and other resources related operations in the People's Republic of China and Mongolia. It sells coking and thermal coal. The company's principal project is the Khushuut coking coal project in Western Mongolia. It holds approximately 12,807 hectares of exploration and mining concession areas for coal and ferrous resources in Western Mongolia at Khushuut, Olon Bulag, and Bayan-Ulgii. It is also involved in offering management, secretarial and nominee, and coal transportation services, as well as mining and exploration advisory services. In addition, the company explores and mines minerals; trades in coal; and operates coal washing plants. Mongolia Energy Corporation Limited was incorporated in 2006 and is headquartered in Hong Kong.
Full MOAEY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.